Literature DB >> 19826888

The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study.

Dimitrios J Pournaras1, Alan Osborne, Simon C Hawkins, David Mahon, Mohammad A Ghatei, Steve R Bloom, Richard Welbourn, Carel W le Roux.   

Abstract

BACKGROUND: Bariatric surgery is the most effective treatment option for obesity, and gut hormones are implicated in the reduction of appetite and weight after Roux-en-Y gastric bypass. Although there is increasing interest in the gut hormone changes after gastric bypass, the long-term changes have not been fully elucidated.
METHODS: Thirty-four participants were studied cross-sectionally at four different time points, pre-operatively (n = 17) and 12 (n = 6), 18 (n = 5) and 24 months (n = 6) after laparoscopic Roux-en-Y gastric bypass. Another group of patients (n = 6) were studied prospectively (18-24 months). All participants were given a standard 400 kcal meal after a 12-h fast, and plasma levels of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) were correlated with changes in appetite over 3 h using visual analogue scores.
RESULTS: The post-operative groups at 12, 18 and 24 months had a higher post-prandial PYY response compared to pre-operative (p < 0.05). This finding was confirmed in the prospective study at 18 and 24 months. There was a trend for increasing GLP-1 response at 18 and 24 months, but this did not reach statistical significance (p = 0.189) in the prospective study. Satiety was significantly reduced in the post-operative groups at 12, 18 and 24 months compared to pre-operative levels (p < 0.05).
CONCLUSIONS: Roux-en-Y gastric bypass causes an enhanced gut hormone response and increased satiety following a meal. This response is sustained over a 24-month period and may partly explain why weight loss is maintained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826888     DOI: 10.1007/s11695-009-9989-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  22 in total

1.  Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up.

Authors:  K D Higa; T Ho; K B Boone
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2001-12       Impact factor: 1.878

2.  Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.

Authors:  Christos Stratis; Theodore Alexandrides; Kostas Vagenas; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2006-06       Impact factor: 4.129

3.  GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

Authors:  Rosa Morínigo; Antonio M Lacy; Roser Casamitjana; Salvadora Delgado; Ramon Gomis; Josep Vidal
Journal:  Obes Surg       Date:  2006-12       Impact factor: 4.129

4.  Peptide YY levels are elevated after gastric bypass surgery.

Authors:  Jean L Chan; Edward C Mun; Violeta Stoyneva; Christos S Mantzoros; Allison B Goldfine
Journal:  Obesity (Silver Spring)       Date:  2006-02       Impact factor: 5.002

5.  GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

Authors:  Camila Puzzi de Carvalho; Daniela Miguel Marin; Aglécio Luiz de Souza; José Carlos Pareja; Elintom Adami Chaim; Silvia de Barros Mazon; Conceição Aparecida da Silva; Bruno Geloneze; Elza Muscelli; Sarah Monte Alegre
Journal:  Obes Surg       Date:  2008-09-25       Impact factor: 4.129

6.  Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.

Authors:  Frédérique Rodieux; Vittorio Giusti; David A D'Alessio; Michel Suter; Luc Tappy
Journal:  Obesity (Silver Spring)       Date:  2008-02       Impact factor: 5.002

7.  Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects.

Authors:  Rosa Morínigo; Josep Vidal; Antonio M Lacy; Salvadora Delgado; Roser Casamitjana; Ramon Gomis
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

8.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 9.  Changes in gut hormones after bariatric surgery.

Authors:  R P Vincent; C W le Roux
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-20       Impact factor: 3.478

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

View more
  36 in total

1.  Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

Authors:  José Manuel Ramón; Silvia Salvans; Xenia Crous; Sonia Puig; Albert Goday; David Benaiges; Lourdes Trillo; Manuel Pera; Luis Grande
Journal:  J Gastrointest Surg       Date:  2012-03-09       Impact factor: 3.452

Review 2.  Bariatric surgery evolution from the malabsorptive to the hormonal era.

Authors:  Ehab Akkary
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 3.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass.

Authors:  Yunfeng Cui; Dariush Elahi; Dana K Andersen
Journal:  J Gastrointest Surg       Date:  2011-06-14       Impact factor: 3.452

Review 6.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

7.  Pre-operative Restraint and Post-operative Hunger, Disinhibition and Emotional Eating Predict Weight Loss at 2 Years Post-laparoscopic Adjustable Gastric Banding.

Authors:  Annemarie Hindle; Xochitl De la Piedad Garcia; Melissa Hayden; Paul E O'Brien; Leah Brennan
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

8.  Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition.

Authors:  Zhibo Yan; Weijie Chen; Shaozhuang Liu; Guangyong Zhang; Dong Sun; Sanyuan Hu
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

9.  Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.

Authors:  Daniela Guarino; Diego Moriconi; Andrea Mari; Eleni Rebelos; Daria Colligiani; Simona Baldi; Marco Anselmino; Ele Ferrannini; Monica Nannipieri
Journal:  Diabetologia       Date:  2018-10-12       Impact factor: 10.122

10.  GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

Authors:  Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.